Skip to Main Content
Back to News

TENET HEALTHCARE Earnings Results: $THC Reports Quarterly Earnings

None

TENET HEALTHCARE ($THC) posted quarterly earnings results on Tuesday, April 29th. The company reported earnings of $4.36 per share, beating estimates of $3.17 by $1.19. The company also reported revenue of $5,223,000,000, beating estimates of $5,208,713,298 by $14,286,702.

You can see Quiver Quantitative's $THC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

TENET HEALTHCARE Insider Trading Activity

TENET HEALTHCARE insiders have traded $THC stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:

  • J ROBERT KERREY has made 0 purchases and 6 sales selling 9,525 shares for an estimated $1,194,752.
  • LISA Y FOO (EVP, Commercial Ops) has made 0 purchases and 2 sales selling 4,000 shares for an estimated $623,744.
  • CECIL D HANEY sold 2,500 shares for an estimated $310,650

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TENET HEALTHCARE Hedge Fund Activity

We have seen 280 institutional investors add shares of TENET HEALTHCARE stock to their portfolio, and 317 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TENET HEALTHCARE Government Contracts

We have seen $36,120 of award payments to $THC over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

TENET HEALTHCARE Analyst Ratings

Wall Street analysts have issued reports on $THC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Morgan Stanley issued a "Overweight" rating on 03/26/2025
  • KeyBanc issued a "Overweight" rating on 01/07/2025

To track analyst ratings and price targets for TENET HEALTHCARE, check out Quiver Quantitative's $THC forecast page.

TENET HEALTHCARE Price Targets

Multiple analysts have issued price targets for $THC recently. We have seen 2 analysts offer price targets for $THC in the last 6 months, with a median target of $162.5.

Here are some recent targets:

  • Matthew Gillmor from KeyBanc set a target price of $185.0 on 01/07/2025
  • Jamie Perse from Goldman Sachs set a target price of $140.0 on 12/16/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles